Publication | Closed Access

Pretreatment Serum Prealbumin as an Independent Prognostic Indicator in Patients With Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors as First-Line Target Therapy

First-line Target TherapyUrologyIndependent Prognostic IndicatorRenal FunctionGenitourinary CancerPreclinical Drug EvaluationPretreatment Serum PrealbuminMedicinePharmacologyPharmacotherapyOncology